The National Cancer Institute (NCI) of the National Institutes of Health (NIH) has issued funding opportunity announcements for R01 research project grants (RFA-CA-17-017) and R21 exploratory/development grants (RFA-CA-17-018) to solve specific problems and paradoxes in cancer research.

Each research project proposed must address one specific provocative question identified by NCI, including, “How do circadian processes affect tumor development, progression, and response to therapy?”